Detalhe da pesquisa
1.
Healthcare costs and resource utilization in patients with migraine treated with erenumab: A retrospective, non-interventional study using claims data from the United States.
Headache
; 63(10): 1423-1436, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37655551
2.
Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study.
J Headache Pain
; 22(1): 27, 2021 Apr 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33874884
3.
Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparison.
J Comp Eff Res
; 13(3): e230122, 2024 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38174577
4.
Early Use of Erenumab vs Nonspecific Oral Migraine Preventives: The APPRAISE Randomized Clinical Trial.
JAMA Neurol
; 81(5): 461-470, 2024 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38526461
5.
Assessment of the relative effectiveness of erenumab compared with onabotulinumtoxinA for the prevention of chronic migraine.
Curr Med Res Opin
; 39(1): 105-112, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36189948
6.
Real-world treatment satisfaction with erenumab in migraine: analysis of the US National Health and Wellness Survey.
Curr Med Res Opin
; 39(12): 1585-1591, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36919462
7.
Effectiveness of erenumab and onabotulinumtoxinA on acute medication usage and health care resource utilization as migraine prevention in the United States.
J Manag Care Spec Pharm
; 27(9): 1157-1170, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-33998825
8.
Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis.
Adv Ther
; 38(6): 2921-2934, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33763828
9.
Real-world migraine-related healthcare resource utilization and costs associated with improved vs. worsened/stable migraine: a panel-based chart review in France, Germany, Italy, and Spain.
J Med Econ
; 24(1): 900-907, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34311659
10.
Management of Migraine and the Accessibility of Specialist Care: Findings from an Extended Multinational Survey (My Migraine Center Survey).
Neurol Ther
; 9(2): 551-565, 2020 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-32767268
11.
Correction to: Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis.
Adv Ther
; 38(8): 4598, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-34273094
12.
Correction to: Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis.
Adv Ther
; 38(6): 2935, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-34003453